Takeda Pharmaceutical Company Limited Interest Expense
Takeda Pharmaceutical Company Limited (TKPHF) reported Interest Expense of JPY 137.31 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Expense Statement › Interest Expense
ifrs-full:InterestExpense · last filed 2025-06-25
| Period end | Interest Expense 12 month |
|---|---|
| 2025-03-31 | 137.31B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 119.53B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 116.97B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 122.43B JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | 130.81B JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | 149.01B JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | 48.16B JPY 20-F · filed 2021-06-29 |
| 2018-03-31 | 10.04B JPY 20-F · filed 2020-06-24 |
| 2017-03-31 | 7.56B JPY 20-F · filed 2019-06-27 |